Tag: NASDAQ:ENLV
November 18, 2019
Enlivex Therapeutics Finishes Recruitment for Phase 1b Trial
Enlivex Therapeutics' Phase 1b clinical trial is evaluating the company's Allocetra in patients with severe sepsis.
October 7, 2019
5 Top NASDAQ Biotech Stocks Year-to-Date
With the last quarter of the year underway, it means it's time to look back on the top-performing NASDAQ biotech... August 19, 2019
Enlivex Reports Outcome from Sepsis Study
Enlivex Therapeutics (NASDAQ:ENLV) has announced data from its ongoing Phase 1b clinical trial in patients with severe sepsis in addition...
July 21, 2019
5 Top Weekly NASDAQ Biotech and Pharma Stocks: Acasta in Lead
Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
July 17, 2019
5 Top NASDAQ Biotech Stocks Year-to-Date
The first half of 2019 is done, which means it's time to look back on the top performing NASDAQ biotech...
June 16, 2019